Dedicated to being the world’s top medical isotope producer through fusion technology.
Based in Janesville, Wisconsin, SHINE Technologies is a next-generation fusion technology company, deploying safe, cost-effective and environmentally friendly systems for use in industrial imaging of components across aerospace, defense, transport, medicine, energy and more. SHINE’s proprietary isotope production processes create both molybdenum-99 and n.c.a. lutetium-177, each of which are used in diagnostic and therapeutic medical procedures. SHINE is currently producing n.c.a. Lu-177, has a Drug Master File in place with the U.S. Food and Drug Administration and is rapidly scaling its production capabilities. It is also currently constructing a 43,000-square-foot facility that will be dedicated to producing fusion-based medical isotopes like Mo-99. SHINE plans to scale its fusion technology to recycle nuclear waste and to generate fusion power to deliver clean, abundant energy that could transform life on Earth. Learn more at www.shinefusion.com and @shinefusion.